These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23258374)

  • 1. Think global--act local: intravitreal drug delivery systems in chronic noninfectious uveitis.
    Hazirolan D; Pleyer U
    Ophthalmic Res; 2013; 49(2):59-65. PubMed ID: 23258374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery options for the treatment of ocular inflammation.
    Lobo AM; Sobrin L; Papaliodis GN
    Semin Ophthalmol; 2010; 25(5-6):283-8. PubMed ID: 21091013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone for ocular inflammation.
    Saraiya NV; Goldstein DA
    Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
    Lee SS; Hughes PM; Robinson MR
    Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
    Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
    Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of intraocular corticosteroids.
    Kiernan DF; Mieler WF
    Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.
    Miserocchi E; Modorati G; Pastore MR; Bandello F
    Ophthalmologica; 2012; 228(4):229-33. PubMed ID: 23038070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
    Malone PE; Herndon LW; Muir KW; Jaffe GJ
    Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Ozkiris A
    Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion.
    Nguyen QD; Callanan D; Dugel P; Godfrey DG; Goldstein DA; Wilensky JT
    Retina; 2006 Oct; Suppl():1-16. PubMed ID: 17050954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in corticosteroid therapy for uveitis.
    Taylor SR; Isa H; Joshi L; Lightman S
    Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and clinical profile of dexamethasone intravitreal implant.
    Robinson MR; Whitcup SM
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):629-47. PubMed ID: 23234323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery methods for posterior segment disease.
    Hsu J
    Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.
    Testi I; Pavesio C
    Ther Deliv; 2019 Oct; 10(10):621-625. PubMed ID: 31663454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.